Related Experiment Videos

Myeloid bodies formation in triparanol treated cultured cells

Virchows Archiv. B, Cell Pathology
|December 19, 1975
PubMed

Insights

Triparanol (MER-29) treatment induced myeloid bodies in cultured cells. These structures, identified as lysosomes, showed acid phosphatase activity late in their development.

Area of Science:

  • Cell Biology
  • Toxicology
  • Biochemistry

Background:

  • Triparanol (MER-29) is a cholesterol synthesis inhibitor.
  • Cellular responses to drug-induced stress are complex.
  • Lysosomal changes can indicate cellular damage or adaptation.

Purpose of the Study:

  • To investigate the ultrastructural effects of triparanol on cultured cells.
  • To characterize the nature and development of drug-induced cytoplasmic structures.
  • To determine the lysosomal involvement in triparanol toxicity.

Main Methods:

  • Culturing of chicken embryo liver cells and rat embryo fibroblasts.
  • Treatment with triparanol (MER-29) for varying durations.
  • Ultrastructural analysis using electron microscopy.
  • Cytochemical staining for acid phosphatase activity.

Main Results:

  • Triparanol induced the formation of numerous myeloid bodies (membranous whorls) in the cytoplasm of both cell types.
  • Different developmental stages of these myeloid bodies were observed.
  • Acid phosphatase activity was detected within the myeloid bodies, confirming their lysosomal nature.
  • Lysosomal activity was evident only in the later stages of myeloid body formation.

Conclusions:

  • Triparanol induces lysosomal alterations in cultured cells.
  • Myeloid bodies represent a lysosomal response to triparanol exposure.
  • The late appearance of acid phosphatase activity suggests a sequential development of these structures.

Related Concept Videos